Cita APA

Fakhouri, F., Hourmant, M., Campistol Plana, J. M., Cataland, S. R., Espinosa, M., Gaber, A. O., . . . Legendre, C. M. (2016). Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.

Citación estilo Chicago

Fakhouri, Fadi, et al. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial. 2016.

Cita MLA

Fakhouri, Fadi, et al. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial. 2016.